Calidi Biotherapeutics Inc (CLDI)
0.2335
0.00 (0.00%)
USD |
NYAM |
May 22, 13:51
Calidi Biotherapeutics Shareholders Equity (Quarterly): -14.57M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -14.57M |
| December 31, 2023 | -8.235M |
| September 30, 2023 | -1.094M |
| June 30, 2023 | -63.71M |
| Date | Value |
|---|---|
| December 31, 2022 | -50.44M |
| September 30, 2022 | -43.93M |
| December 31, 2021 | -31.61M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-63.71M
Minimum
Jun 2023
-1.094M
Maximum
Sep 2023
-30.51M
Average
-31.61M
Median
Dec 2021
Shareholders Equity (Quarterly) Benchmarks
| Minerva Neurosciences Inc | -36.59M |
| Viking Therapeutics Inc | 933.89M |
| CytomX Therapeutics Inc | -31.68M |
| Genprex Inc | 8.757M |
| Janux Therapeutics Inc | 655.76M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.405M |
| Total Liabilities (Quarterly) | 21.98M |